C9142 Insurance Policy Changes
HCPCS C9142 is officially defined as "Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg." No tracked policy changes reference HCPCS C9142 yet. New payer updates are added daily, so check back soon or create a free alert to be notified the moment a change affects this code.
No policies yet
No tracked policy changes match this filter yet. New policies are added daily.
Watch C9142
Get one email when a payer policy names C9142, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for C9142
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for C9142 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.